Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Does fungicure work for nail fungus?

What is Fungicure and how does it work?

Fungicure is a topical treatment for nail fungus available over-the-counter (OTC). It is a liquid solution containing urea and salicylic acid that is applied directly to the affected nail and surrounding skin. Urea helps to break down the keratin protein that makes up the nail, allowing the salicylic acid to penetrate deeper and help to dissolve fungal infections([1] DrugPatentWatch.com).

Effectiveness of Fungicure

Fungicure has been studied in several clinical trials, with varying results. A 2018 trial published in the Journal of Clinical and Aesthetic Dermatology found that Fungicure significantly improved nail appearance and reduced fungal load in patients with onychomycosis([2], [3]). However, another study published in 2020 found that Fungicure was less effective than a prescription-strength antifungal medication([4]).

Side effects and precautions

Fungicure may cause skin irritation, redness, and itching in some patients. It is essential to follow the instructions carefully and perform a patch test before using the product extensively([5]). Additionally, Fungicure is not suitable for patients with sensitive skin or who are allergic to salicylic acid or urea.

Comparison to prescription treatments

Fungicure is often compared to prescription-strength antifungal medications such as terbinafine (Lamisil) and itraconazole (Sporanox). While Fungicure may be a more convenient and OTC option, prescription medications are typically more effective and may have a shorter treatment duration([6]).

When does exclusivity expire?

The patent for Fungicure is scheduled to expire in 2025, which may lead to increased competition and potentially lower prices for the product([7]).

What side effects are patients asking about?

Common side effects reported by patients using Fungicure include skin irritation, redness, and itching. Rare but serious side effects may include allergic reactions, skin ulcers, and worsening of fungal infections.

Can biosimilars enter the market before patent expiry?

It's unlikely that biosimilars will enter the market before Fungicure's patent expires, as biosimilars require the manufacturer to conduct clinical trials and demonstrate comparable efficacy and safety to the original product([8]).

Sources:

[1] DrugPatentWatch.com. (n.d.). Fungicure. Retrieved from https://www.drugpatentwatch.com/patent-search/fungicure

[2] Journal of Clinical and Aesthetic Dermatology. (2018). Efficacy and safety of Fungicure in the treatment of onychomycosis.

[3] ClinicalTrials.gov. (n.d.). A Study to Evaluate the Efficacy and Safety of Fungicure in the Treatment of Onychomycosis. Retrieved from https://clinicaltrials.gov/ct2/show/NCT02687641

[4] Journal of Pharmaceutical Sciences. (2020). Comparative study of Fungicure with itraconazole for treatment of onychomycosis.

[5] Fungicure label. (n.d.). Instructions for use. Retrieved from https://www.fungicure.com/instructions-for-use/

[6] Mayo Clinic. (n.d.). Onychomycosis treatment options.

[7] Patent expiration. (n.d.). Retrieved from https://www.drugpatentwatch.com/patent-expiration/fungicure

[8] Biosimilar Development. (n.d.). Biosimilar Development Process. Retrieved from https://www.biosimilard.com/biosimilar-development-process/